HCPCS Q4211 is officially defined as "Amnion bio or axobiomembrane, per square centimeter (add-on, list separately in addition to primary procedure)." HCPCS Q4211 is referenced in 4 tracked payer policy changes from Sentara Health Plans, Health Net, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS Q4211 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Starting January 1, 2027, Sentara Health Plans will require prior authorization for a long list of codes on Virginia commercial plans, including self-funded (ASO) plans, and for code 88380 on commercial, Medicaid and Medicare products, plus code 22860 on Medicare products. Sentara will also stop covering a separate list of codes on Virginia commercial and self-funded plans.
Health Net California is updating prior authorization requirements effective December 1, 2025, removing PA requirements for many DME items, prosthetics, sleep studies, varicose vein treatments, and therapy services while maintaining PA requirements for non-emergency air transport, hysterectomies, and skin substitutes. These changes aim to reduce administrative burden and streamline approval processes.
CalViva Health (Medi-Cal) updated multiple medical policies for Q2 2021, affecting prior authorization requirements, billing codes, and coverage criteria across numerous specialties. Key changes include updated CPT codes for ADHD testing, nerve studies, and spinal procedures, plus revised criteria for gender-affirming procedures, pain management, and wound care.
Lipectomy or liposuction for lymphedema or lipedema changed from investigational to medically necessary when criteria are met, including significant physical impairment, no response to at least 3 consecutive months of conservative treatment, and continued use of compression garments after surgery. Pharmacy criteria added Valtoco for epilepsy in patients ages 6 and older, required that patients have tried and failed at least one generic anti-seizure medication for Epidiolex, and added Reblozyl for anemia in adults ages 18 and older with beta thalassemia. Coding updates require medical necessity and prior authorization review for CPT 55874 on and after May 17, 2020, removed that review for HCPCS L8692, and require review for investigative status for Q4205, Q4206, Q4208 through Q4219 and Q4221.
Watch Q4211
Get one email when a payer policy names Q4211, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for Q4211
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for Q4211 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.